[{"address1": "10628 Science Center Drive", "address2": "Suite 250", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 900 2660", "website": "https://arcturusrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Arcturus Therapeutics Holdings Inc. engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms includes LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate that is in phase 2 clinical trial for cystic fibrosis. Its product pipeline includes KOSTAIVE for the treatment of covid 19; ARCT-2138 (LUNAR-FLU), which is in phase 1 clinical trial for the treatment of seasonal influenza; ARCT-2304 (LUNAR-H5N1) that is in phase 1 clinical trial for the treatment of Pandemic Influenza; ARCT-2301 for bivalent: ancestral/omicron which is in Phase 3 clinical trial; and ARCT-2303 for monovalent that is in Phase 3 clinical trial. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.", "fullTimeEmployees": 174, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joseph E. Payne M.Sc.", "age": 52, "title": "Founder, President, CEO & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 1062000, "exercisedValue": 0, "unexercisedValue": 2086450}, {"maxAge": 1, "name": "Dr. Padmanabh  Chivukula Ph.D.", "age": 45, "title": "Founder, Chief Scientific Officer, COO & Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 778000, "exercisedValue": 0, "unexercisedValue": 1370925}, {"maxAge": 1, "name": "Mr. Andrew H. Sassine MBA", "age": 60, "title": "CFO & Director", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 811000, "exercisedValue": 0, "unexercisedValue": 1901388}, {"maxAge": 1, "name": "Mr. Lance  Kurata", "title": "Chief Legal Officer", "fiscalYear": 2024, "totalPay": 680000, "exercisedValue": 0, "unexercisedValue": 3125}, {"maxAge": 1, "name": "Ms. Neda  Safarzadeh", "title": "Vice President and Head of IR/PR & Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Natasha O. Bowman", "title": "Chief Human Resources Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin T. Skol", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Juergen  Froehlich FCPh, M.D., MBA", "age": 68, "title": "Chief Medical Officer", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Igor  Smolenov M.D., Ph.D.", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Roberta  Duncan", "title": "Chief Strategy Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 3, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 7, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.63, "open": 9.81, "dayLow": 9.6535, "dayHigh": 10.04, "regularMarketPreviousClose": 9.63, "regularMarketOpen": 9.81, "regularMarketDayLow": 9.6535, "regularMarketDayHigh": 10.04, "payoutRatio": 0.0, "beta": 2.388, "forwardPE": -4.470852, "volume": 918212, "regularMarketVolume": 918212, "averageVolume": 1195164, "averageVolume10days": 3500230, "averageDailyVolume10Day": 3500230, "bid": 7.21, "ask": 12.49, "bidSize": 2, "askSize": 2, "marketCap": 270730656, "fiftyTwoWeekLow": 8.04, "fiftyTwoWeekHigh": 24.17, "allTimeHigh": 188.72, "allTimeLow": 4.11, "priceToSalesTrailing12Months": 2.2168868, "fiftyDayAverage": 17.9708, "twoHundredDayAverage": 14.75455, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 101227656, "profitMargins": -0.49265, "floatShares": 25017468, "sharesOutstanding": 27154529, "sharesShort": 5310305, "sharesShortPriorMonth": 5947408, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.19559999, "heldPercentInsiders": 0.07882, "heldPercentInstitutions": 0.89623, "shortRatio": 5.82, "shortPercentOfFloat": 0.3023, "impliedSharesOutstanding": 27154529, "bookValue": 8.511, "priceToBook": 1.1714253, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -60164000, "trailingEps": -2.22, "forwardEps": -2.23, "lastSplitFactor": "1:7", "lastSplitDate": 1510790400, "enterpriseToRevenue": 0.829, "enterpriseToEbitda": -1.462, "52WeekChange": -0.4405163, "SandP52WeekChange": 0.19736934, "quoteType": "EQUITY", "currentPrice": 9.97, "targetHighPrice": 140.0, "targetLowPrice": 12.0, "targetMeanPrice": 44.75, "targetMedianPrice": 21.5, "recommendationMean": 1.63636, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 196467008, "totalCashPerShare": 7.235, "ebitda": -69262000, "totalDebt": 26964000, "quickRatio": 4.594, "currentRatio": 5.901, "totalRevenue": 122122000, "debtToEquity": 11.67, "revenuePerShare": 4.507, "returnOnAssets": -0.12999, "returnOnEquity": -0.24575001, "grossProfits": -70926000, "freeCashflow": -47599124, "operatingCashflow": -64941000, "revenueGrowth": -0.432, "grossMargins": -0.58077997, "ebitdaMargins": -0.56715, "operatingMargins": -0.41044, "financialCurrency": "USD", "symbol": "ARCT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "shortName": "Arcturus Therapeutics Holdings ", "longName": "Arcturus Therapeutics Holdings Inc.", "corporateActions": [], "postMarketTime": 1761954786, "regularMarketTime": 1761940800, "exchange": "NGM", "messageBoardId": "finmb_235062181", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 3.53063, "regularMarketPrice": 9.97, "postMarketChangePercent": 0.6018, "postMarketPrice": 10.03, "postMarketChange": 0.059999466, "regularMarketChange": 0.34, "regularMarketDayRange": "9.6535 - 10.04", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1195164, "fiftyTwoWeekLowChange": 1.9300003, "fiftyTwoWeekLowChangePercent": 0.2400498, "fiftyTwoWeekRange": "8.04 - 24.17", "fiftyTwoWeekHighChange": -14.2, "fiftyTwoWeekHighChangePercent": -0.58750516, "fiftyTwoWeekChangePercent": -44.05163, "dividendDate": 1510790400, "earningsTimestamp": 1762804800, "earningsTimestampStart": 1762804800, "earningsTimestampEnd": 1762804800, "earningsCallTimestampStart": 1762810200, "earningsCallTimestampEnd": 1762810200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.22, "epsForward": -2.23, "epsCurrentYear": -2.63049, "priceEpsCurrentYear": -3.7901683, "fiftyDayAverageChange": -8.0008, "fiftyDayAverageChangePercent": -0.4452111, "twoHundredDayAverageChange": -4.7845497, "twoHundredDayAverageChangePercent": -0.3242762, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1369229400000, "marketState": "CLOSED", "displayName": "Arcturus Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-01"}]